Rossby Financial’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72.9K Sell
1,380
-3,100
-69% -$158K 0.01% 630
2025
Q4
$229K Sell
4,480
-200
-4% -$9.25K 0.07% 259
2025
Q3
$182K Hold
4,680
0.06% 303
2025
Q2
$141K Sell
4,680
-500
-10% -$14.3K 0.05% 316
2025
Q1
$147K Buy
+5,180
New +$164K 0.06% 286

Other funds holding SBIO

Rossby Financial's SBIO Position: Q1 2026 in Review

Rossby Financial reduced its ALPS Medical Breakthroughs ETF (SBIO) stake by 69% in Q1 2026, selling an estimated $158K and leaving 1,380 shares worth $72.9K. The position accounts for 0.01% of the portfolio, ranked #630.

Rossby Financial first reported a position in SBIO in Q1 2025 and has held it in 5 quarters since. The position peaked at $229K in Q4 2025. 59 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.

  • Rossby Financial held 1,380 shares of ALPS Medical Breakthroughs ETF worth $72.9K as of Q1 2026.
  • Rossby Financial sold 3,100 ALPS Medical Breakthroughs ETF shares in Q1 2026, an estimated $158K.
  • ALPS Medical Breakthroughs ETF made up 0.01% of Rossby Financial's portfolio in Q1 2026, its #630 holding.
  • Rossby Financial first reported a position in ALPS Medical Breakthroughs ETF in Q1 2025 and has held it in 5 quarters since.
  • Rossby Financial's ALPS Medical Breakthroughs ETF position peaked at $229K in Q4 2025.
  • 59 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.

Based on Rossby Financial's 13F filing for Q1 2026, filed 11 May 2026.